Browsing: Weight Loss

SAN FRANCISCO, California: Eli Lilly has filed lawsuits against six U.S. companies it accuses of illegally selling black-market versions of its experimental obesity drug retatrutide, stepping up action against unauthorized sellers before the medicine has received regulatory approval

Novo Nordisk (NYSE:NVO) CEO Mike Doustdar is defending the drugmaker’s lawsuit against Eli Lilly (NYSE:LLY), escalating a fight over how the two companies market their blockbuster obesity treatments. The legal battle matters because Lilly has seized the lead in the U.S. obesity-drug market, raising the stakes for Novo as it tries to narrow the efficacy…